All data are based on the daily closing price as of December 31, 2025
t
Towa Pharmaceutical
4553.TSE
23.35 USD
-0.46
-1.93%
Overview
Last close
23.35 usd
Market cap
1.15B usd
52 week high
24.03 usd
52 week low
16.24 usd
Target price
24.77 usd
Valuation
P/E
8.6805
Forward P/E
16.7785
Price/Sales
0.672
Price/Book Value
1.0182
Enterprise Value
2.36B usd
EV/Revenue
1.3868
EV/EBITDA
7.1962
Key financials
Revenue TTM
1.70B usd
Gross Profit TTM
619.51M usd
EBITDA TTM
284.64M usd
Earnings per Share
2.68 usd
Dividend
0.51 usd
Total assets
3.25B usd
Net debt
1.26B usd
About
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. The company was founded in 1951 and is headquartered in Osaka, Japan.